Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 33NETWORK 3OTHER_GOV 2

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 3

Interventions

Radiotherapy 302Cisplatin 266Cyclophosphamide 230Doxorubicin 177Paclitaxel 170Vincristine 162Carboplatin 152Filgrastim 140Etoposide 139Gemcitabine 118Docetaxel 114Fluorouracil 113Methotrexate 106Dexamethasone 106Cytarabine 106Prednisone 92Leucovorin 90Gene Expression Profiling 82Granulocyte Colony-Stimulating Factor 75Specimen Handling 70Magnetic Resonance Spectroscopy 63Irinotecan 59Capecitabine 59Radiation 54Polymerase Chain Reaction 51Ifosfamide 51Rituximab 49Immunohistochemistry 49Daunorubicin 49Oxaliplatin 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Gastrectomy × Clear all
NCT02205047 2025-07-31

INNOVATION

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
172 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01924819 2025-03-04

TOPGEAR

Australasian Gastro-Intestinal Trials Group

Phase 2/3 Active not recruiting
574 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00335959 2012-08-17

S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery

SWOG Cancer Research Network

Phase 2 Terminated
7 enrolled 7 charts
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡